By Bryan Koenig ( November 4, 2021, 7:09 PM EDT) -- Federal Trade Commission staffers want a group of antitrust, patent and economics academics barred from backing DNA sequencing company Illumina's $8 billion reacquisition of Grail against an agency in-house merger challenge, suggesting that their proposed amicus brief is part of the companies' public relations campaign....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.